companydata.dkcompanydata.dk

MATRIX PHARMACEUTICALS ApS: Financial statements 2015

CVR: 29625867

Source: annual report 2015, Danish Business Authority

01/01/201531/12/2015

MATRIX PHARMACEUTICALS ApS (CVR 29625867) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 449,556 and a net result of DKK 210,538 compared with DKK 753,731 the year before. That is a decrease of 51.6% compared with the year before. Equity in the 2015 report amounted to DKK 797,126. The solvency ratio was 27.9%.

Gross Profit
DKK 449,556
Profit/Loss
DKK 210,538
Equity
DKK 797,126
Total Assets
DKK 2,859,175

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2015-450 t.211 t.797 t.-
2014-929 t.754 t.587 t.-
20138.6 mio.1.2 mio.961 t.-167 t.-
20124.5 mio.264 t.79 t.-1.1 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is MATRIX PHARMACEUTICALS ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2015

MATRIX PHARMACEUTICALS ApS: The 2014 annual report is outJun 16, 2015

MATRIX PHARMACEUTICALS ApS has published its annual report for 2014. Gross profit came to DKK 928,617, and the net result was DKK 753,731.

MATRIX PHARMACEUTICALS ApS appoints new auditorMay 27, 2015

As of May 27, 2015, BHA STATSAUTORISERET REVISION APS has been appointed auditor of MATRIX PHARMACEUTICALS ApS.

About MATRIX PHARMACEUTICALS ApS

MATRIX PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2006. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Karsten Høilund Skafte. The board consists of Karsten Høilund Skafte. The company is owned by Karsten Høilund Skafte and KHS HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported revenue of DKK 1,090,380 and a net result of DKK 589,123 compared with DKK 440,028 the year before. Equity in the 2025 report amounted to DKK 589,123.

Source: annual report 2025, Danish Business Authority